Table 3.

Tumor weight, tumor growth, and response to cisplatin was the same in CXCR2^−/− vs. WT mice

Experiment 1	WT Veh, n = 8	WT Cis, n = 6	CXCR2−/− Veh, n = 7	CXCR2−/− Cis, n = 6
Tumor weight, g	0.9 ± 0.09	0.2 ± 0.04*	0.7 ± 0.2	0.3 ± 1**
Tumor volume week 1, mm3	46 ± 10	14 ± 6	81 ± 14	13 ± 6
Tumor volume week 2, mm3	152 ± 25+	66 ± 20++	137 ± 36	43 ± 13++++
Tumor volume week 3, mm3	404 ± 139+	84 ± 32++	184 ± 37+++	76 ± 29++++
Tumor volume week 4, mm3	444 ± 266+	81 ± 14++	274 ± 62+++	112 ± 62

NS,  not significant.

^*P < 0.001 vs. WT Veh;

^**P < 0.05 vs. CXCR2^−/− Veh, NS vs. WT Cis;

⁺P < 0.05 vs. week 1;

⁺⁺P < 0.05 vs. week 1, P < 0.05 vs. WT Veh;

⁺⁺⁺P < 0.05 vs. week 1, NS vs. WT Veh;

⁺⁺⁺⁺P < 0.05 vs. week 1, P < 0.05 vs. CXCR2^−/− Veh.